Galanin (1-13)-Bradykinin (2-9) amide
Supplier: BACHEM AMERICAS INC
4020106.0500
4020106.1000
H-1346.0500BAEA
391.92
CAD
H-1346.0500BA
H-1346.1000BA
Galanin (1-13)-Bradykinin (2-9) amide
Proteins and Peptides
The galanin antagonist M35, which binds with high specificity and affinity to galanin binding sites, has been administered to rats to test the functional consequences of the galanin receptor blockade in a spatial learning task. The results suggest that galanin antagonists might provide a new principle in the treatment of dementia and related disorders. M35 (but not M40 or C7) ameliorated cerulein-induced acute pancreatitis in mice.
Learn more

About VWR
Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...